Glen Research

Glen Research is a long-established, private US company operating as a critical enabler in the oligonucleotide synthesis supply chain. It provides a comprehensive suite of high-purity chemical reagents, including novel phosphoramidites and solid supports, primarily for research and diagnostic applications. The company has built a strong reputation over more than 30 years for product quality and technical expertise, as evidenced by its industry-leading technical newsletter, The Glen Report. Its business model is focused on selling consumable reagents and supports to academic, biotech, and diagnostic customers rather than developing its own therapeutic pipeline.

Provider of phosphoramidite chemistry and solid supports for the chemical synthesis, modification, and purification of DNA and RNA oligonucleotides. Expertise includes UltraMild protecting groups, locked nucleic acid (LNA) analogs, and a wide array of modified nucleosides and labels.

Operates in a competitive niche with players like Sigma-Aldrich (MilliporeSigma), Thermo Fisher Scientific, and specialized firms like ChemGenes and Link Technologies. Glen Research differentiates through deep technical expertise, a focused product portfolio, a reputation for quality, and thought leadership via its technical newsletter, catering to a sophisticated customer base.